FDA
-
-
-
-
-
-
-
AbbVie's Rinvoq gets positive EU panel opinion for hair loss
-
-
-
-
-
-
-
EU approves AbbVie's Skyrizi for children with plaque psoriasis
-
-
-
-
-
-
-
FDA approves AbbVie's DECNUPAZ for rare blood cancer treatment
-
-
-
-
-
-
-
AbbVie Reports First-Quarter 2026 Financial Results
-
-
-
-
-
-
-
AbbVie presents phase 2 ovarian cancer trial data at SGO meeting
-
-
-
-
-
-
-
FDA approves AbbVie's VENCLEXTA-acalabrutinib combo for untreated CLL
-
-
-
-
-
-
-
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Adults and Adolescents With Vitiligo
-
325,657 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

